Quintiles, a US-based biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, is now providing  data management services in Shanghai, Chinafor the Asia-Pacific region.

Quintiles, a pioneer in the Asia-Pacific clinical research industry. Since 1993 when the company opened it's first office in the region,  it has grown to more than 20 offices in 14 countries throughout the region with its regional headquarters in Singapore.

“China is an integral component of the new health landscape, quickly becoming one of the key markets for biopharmaceutical development and innovation,” said Ling Zhen, General Manager, Quintiles China. “As a pioneer in the China clinical development industry, we have seen tremendous growth in demand for our services as biopharmaceutical customers look to enhance their operational efficiencies and position in this growing market.”

Lalit Pai, Head, Quintiles Global Data Management, said: “With regional data management operations in Japan, India and now China, Quintiles can continue to deliver operational efficiencies and cost-savings for our customers, while offering services in local time zones with local expertise. The Shanghai expansion will allow us to lead biometrics in China, serving local customers, as well as customers throughout Asia-Pacific.”

Quintiles’ dedicated team of data management professionals in Shanghai will work closely with the company’s biostatistics and medical writing teams in China, to accommodate customer demand for increased efficiencies through integrated services.

Quintiles China has offices in Beijing and Hong Kong andShanghai, opened its first office in the region in 1993.